Please wait while the formulary information is being retrieved.
TOBRAMYCIN (TOBRAMYCIN SULFATE)
- Respiratory cystic fibrosis p. aeruginosa colonization
- Synergy for p. aeruginosa infection in cystic fibrosis
- Bacterial blepharitis
- Bacterial conjunctivitis
- Blepharoconjunctivitis
- Dacryocystitis
- Keratoconjunctivitis
- Meibomianitis
- Tobrex Eye Drops
- Tobramycin In 0.225 % Sodium Chloride For Nebulization
- Tobramycin Eye Drops
- Tobi Solution For Nebulization
- By Indication
0.3 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
300 mg/5 mL in 0.225 % sodium chloride for nebulization
- Inhale 5 milliliters (300 mg) via nebulizer by inhalation route every12 hours
tobramycin 300 mg/5 mL in 0.225 % sodium chloride for nebulization
- Inhale 5 milliliters (300 mg) via nebulizer by inhalation route every12 hours
0.3 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
300 mg/5 mL solution for nebulization
- Inhale 5 milliliters (300 mg) via nebulizer by inhalation route every12 hours
Bacterial blepharitis
- Instill 2 drops into left eye by ophthalmic route every 4 hours
- Instill 2 drops into right eye by ophthalmic route every 4 hours
- Instill 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into right eye by ophthalmic route every 4 hours
- Instill 1 - 2 drops into left eye by ophthalmic route every 4 hours
- Instill 1 drop into left eye by ophthalmic route every 4 hours
- Instill 1 drop into right eye by ophthalmic route every 4 hours
- Instill 1 drop into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
- Instill 2 drops into affected eye(s) by ophthalmic route every 4 hours
- Instill 1 - 2 drops into affected eye(s) by ophthalmic route every 4 hours
Bacterial conjunctivitis
- Instill 2 drops into left eye by ophthalmic route every 4 hours
- Instill 2 drops into right eye by ophthalmic route every 4 hours
- Instill 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into right eye by ophthalmic route every 4 hours
- Instill 1 - 2 drops into left eye by ophthalmic route every 4 hours
- Instill 1 drop into left eye by ophthalmic route every 4 hours
- Instill 1 drop into right eye by ophthalmic route every 4 hours
- Instill 1 drop into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
- Instill 2 drops into affected eye(s) by ophthalmic route every 4 hours
- Instill 1 - 2 drops into affected eye(s) by ophthalmic route every 4 hours
Blepharoconjunctivitis
- Instill 2 drops into left eye by ophthalmic route every 4 hours
- Instill 2 drops into right eye by ophthalmic route every 4 hours
- Instill 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into right eye by ophthalmic route every 4 hours
- Instill 1 - 2 drops into left eye by ophthalmic route every 4 hours
- Instill 1 drop into left eye by ophthalmic route every 4 hours
- Instill 1 drop into right eye by ophthalmic route every 4 hours
- Instill 1 drop into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
- Instill 2 drops into affected eye(s) by ophthalmic route every 4 hours
- Instill 1 - 2 drops into affected eye(s) by ophthalmic route every 4 hours
Dacryocystitis
- Instill 2 drops into left eye by ophthalmic route every 4 hours
- Instill 2 drops into right eye by ophthalmic route every 4 hours
- Instill 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into right eye by ophthalmic route every 4 hours
- Instill 1 - 2 drops into left eye by ophthalmic route every 4 hours
- Instill 1 drop into left eye by ophthalmic route every 4 hours
- Instill 1 drop into right eye by ophthalmic route every 4 hours
- Instill 1 drop into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
- Instill 2 drops into affected eye(s) by ophthalmic route every 4 hours
- Instill 1 - 2 drops into affected eye(s) by ophthalmic route every 4 hours
Keratoconjunctivitis
- Instill 2 drops into left eye by ophthalmic route every 4 hours
- Instill 2 drops into right eye by ophthalmic route every 4 hours
- Instill 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into right eye by ophthalmic route every 4 hours
- Instill 1 - 2 drops into left eye by ophthalmic route every 4 hours
- Instill 1 drop into left eye by ophthalmic route every 4 hours
- Instill 1 drop into right eye by ophthalmic route every 4 hours
- Instill 1 drop into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
- Instill 2 drops into affected eye(s) by ophthalmic route every 4 hours
- Instill 1 - 2 drops into affected eye(s) by ophthalmic route every 4 hours
Meibomianitis
- Instill 2 drops into left eye by ophthalmic route every 4 hours
- Instill 2 drops into right eye by ophthalmic route every 4 hours
- Instill 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into right eye by ophthalmic route every 4 hours
- Instill 1 - 2 drops into left eye by ophthalmic route every 4 hours
- Instill 1 drop into left eye by ophthalmic route every 4 hours
- Instill 1 drop into right eye by ophthalmic route every 4 hours
- Instill 1 drop into both eyes by ophthalmic route every 4 hours
- Instill 1 - 2 drops into both eyes by ophthalmic route every 4 hours
- Instill 1 drop into affected eye(s) by ophthalmic route every 4 hours
- Instill 2 drops into affected eye(s) by ophthalmic route every 4 hours
- Instill 1 - 2 drops into affected eye(s) by ophthalmic route every 4 hours
Respiratory cystic fibrosis p. aeruginosa colonization
- Inhale 5 milliliters (300 mg) via nebulizer by inhalation route every12 hours
- Inhale 5 milliliters (300 mg) via nebulizer by inhalation route every12 hours for 28 days
Synergy for p. aeruginosa infection in cystic fibrosis
- Inhale 5 milliliters (300 mg) via nebulizer by inhalation route every12 hours
- Inhale 5 milliliters (300 mg) via nebulizer by inhalation route every12 hours for 28 days
- typhoid vaccine
- Vivotif Berna Vaccine
Contraindicated
- abobotulinumtoxinA
- Anectine
- atracurium
- Botox
- Botox Cosmetic
- cisatracurium
- Compound 347
- Dysport
- enflurane
- Forane
- incobotulinumtoxinA
- isoflurane
- Myobloc
- Nimbex
- onabotulinumtoxinA
- pancuronium
- Quelicin
- rimabotulinumtoxinB
- rocuronium
- succinylcholine chloride
- Terrell
- vecuronium bromide
- Xeomin
- Zemuron
Severe
Moderate
- ampicillin sodium
- ampicillin-sulbactam
- Bicillin C-r
- Bicillin L-a
- Cedax
- cefaclor
- cefadroxil
- cefazolin
- cefazolin in dextrose (iso-os)
- cefdinir
- cefepime
- cefepime in dextrose 5 %
- cefepime in dextrose,iso-osm
- cefotaxime
- cefotetan
- cefotetan in dextrose, iso-osm
- cefoxitin
- cefoxitin in dextrose 3.9 %
- cefoxitin in dextrose, iso-osm
- cefpodoxime
- cefprozil
- ceftazidime
- ceftazidime in D5W
- ceftazidime-dextrose (iso-osm)
- ceftibuten
- Ceftin
- ceftriaxone
- ceftriaxone in dextrose,iso-os
- cefuroxime axetil
- cefuroxime in sterile water
- cefuroxime sodium
- cefuroxime-dextrose (iso-osm)
- cephalexin
- Claforan
- ethacrynate sodium
- Fortaz
- Fortaz In Dextrose 5 %
- furosemide
- Keflex
- Lasix
- mannitol 10 %
- mannitol 15 %
- mannitol 20 %
- mannitol 25 %
- mannitol 5 %
- Maxipime
- Mefoxin In Dextrose (iso-osm)
- nafcillin
- nafcillin in dextrose iso-osm
- Osmitrol 10 %
- Osmitrol 15 %
- Osmitrol 20 %
- Osmitrol 5 %
- oxacillin
- oxacillin in dextrose(iso-osm)
- penicillin G benzathine
- penicillin G benzathine & proc
- penicillin G pot in dextrose
- penicillin G potassium
- penicillin G procaine
- penicillin G sodium
- Pfizerpen-g
- piperacillin-tazobactam
- piperacillin-tazobactam-dextrs
- Rocephin
- Sodium Edecrin
- Tazicef
- ticarcillin-clavulanate
- Timentin
- Unasyn
- Zinacef
- Zinacef In Sterile Water
- Zosyn
- Zosyn In Dextrose (iso-osm)
- None
Contraindicated
- Disorder of the 8th cranial nerve
- Kidney disease with reduction in GFR
- Myasthenia gravis
- Parkinsonism
- Tinnitus
- Vertigo
Severe
Moderate
- Asthma
- Chronic obstructive pulmonary disease
- No disease contraindications
TOBRAMYCIN (TOBRAMYCIN SULFATE)
- Respiratory cystic fibrosis p. aeruginosa colonization
- Synergy for p. aeruginosa infection in cystic fibrosis
- Bacterial blepharitis
- Bacterial conjunctivitis
- Blepharoconjunctivitis
- Dacryocystitis
- Keratoconjunctivitis
- Meibomianitis
- None
- Cough
- Diarrhea
- Dyspnea
- Fever
- Headache disorder
- Hemoptysis
- Voice change
More Frequent
Severe
Less Severe
- Ocular inflammation
- Ocular itching
- Ocular redness
- Blurred vision
- Dysgeusia
- Laryngitis
- Myalgias
- Nausea
- Non-cardiac chest pain
- Ocular irritation
- Ocular pain
- Pharyngitis
- Tinnitus
- Vomiting
- Weight loss
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Aphonia
- Auditory neurotoxicity
- Bronchospastic pulmonary disease
- Nephrotoxicity
- Neuromuscular blockade
- Ototoxicity
- Punctate keratitis
Less Severe
- Anorexia
- Ataxia
- Dizziness
- Eyelid edema
- Pain in oropharynx
- Pruritus of skin
- Skin rash
- Urticaria
- Vertigo
- Wheezing
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Tobramycin (Inhal)
Safety and efficacy under the age of 6 years not established.
Safety and efficacy below the age of 2 months not established.
- 1 Day – 6 Years
- Safety and efficacy under the age of 6 years not established.
- 1 Day – 59 Days
- Safety and efficacy under the age of 6 years not established.
Tobramycin (Ophth)
Safety and efficacy under the age of 6 years not established.
Safety and efficacy below the age of 2 months not established.
- 1 Day – 6 Years
- Safety and efficacy below the age of 2 months not established.
- 1 Day – 59 Days
- Safety and efficacy below the age of 2 months not established.
Tobramycin (inh)
- Severity Level:
2
- Additional Notes: Systemic absorption is likely low after oral inhalation
Tobramycin Sulfate (ophthalmic)
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Tobramycin
Poor oral absorption; unlikely clinically significant levels in infant
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Poor oral absorption; unlikely clinically significant levels in infant |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Bacterial blepharitis | |
| H01.0 | Blepharitis |
| H01.00 | Unspecified blepharitis |
| H01.001 | Unspecified blepharitis right upper eyelid |
| H01.002 | Unspecified blepharitis right lower eyelid |
| H01.003 | Unspecified blepharitis right eye, unspecified eyelid |
| H01.004 | Unspecified blepharitis left upper eyelid |
| H01.005 | Unspecified blepharitis left lower eyelid |
| H01.006 | Unspecified blepharitis left eye, unspecified eyelid |
| H01.009 | Unspecified blepharitis unspecified eye, unspecified eyelid |
| H01.00A | Unspecified blepharitis right eye, upper and lower eyelids |
| H01.00B | Unspecified blepharitis left eye, upper and lower eyelids |
| H01.01 | Ulcerative blepharitis |
| H01.011 | Ulcerative blepharitis right upper eyelid |
| H01.012 | Ulcerative blepharitis right lower eyelid |
| H01.013 | Ulcerative blepharitis right eye, unspecified eyelid |
| H01.014 | Ulcerative blepharitis left upper eyelid |
| H01.015 | Ulcerative blepharitis left lower eyelid |
| H01.016 | Ulcerative blepharitis left eye, unspecified eyelid |
| H01.019 | Ulcerative blepharitis unspecified eye, unspecified eyelid |
| H01.01A | Ulcerative blepharitis right eye, upper and lower eyelids |
| H01.01B | Ulcerative blepharitis left eye, upper and lower eyelids |
| H01.02 | Squamous blepharitis |
| H01.021 | Squamous blepharitis right upper eyelid |
| H01.022 | Squamous blepharitis right lower eyelid |
| H01.023 | Squamous blepharitis right eye, unspecified eyelid |
| H01.024 | Squamous blepharitis left upper eyelid |
| H01.025 | Squamous blepharitis left lower eyelid |
| H01.026 | Squamous blepharitis left eye, unspecified eyelid |
| H01.029 | Squamous blepharitis unspecified eye, unspecified eyelid |
| H01.02A | Squamous blepharitis right eye, upper and lower eyelids |
| H01.02B | Squamous blepharitis left eye, upper and lower eyelids |
| Bacterial conjunctivitis | |
| H10.02 | Other mucopurulent conjunctivitis |
| H10.021 | Other mucopurulent conjunctivitis, right eye |
| H10.022 | Other mucopurulent conjunctivitis, left eye |
| H10.023 | Other mucopurulent conjunctivitis, bilateral |
| H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
| H10.3 | Unspecified acute conjunctivitis |
| H10.30 | Unspecified acute conjunctivitis, unspecified eye |
| H10.31 | Unspecified acute conjunctivitis, right eye |
| H10.32 | Unspecified acute conjunctivitis, left eye |
| H10.33 | Unspecified acute conjunctivitis, bilateral |
| Blepharoconjunctivitis | |
| H10.5 | Blepharoconjunctivitis |
| H10.50 | Unspecified blepharoconjunctivitis |
| H10.501 | Unspecified blepharoconjunctivitis, right eye |
| H10.502 | Unspecified blepharoconjunctivitis, left eye |
| H10.503 | Unspecified blepharoconjunctivitis, bilateral |
| H10.509 | Unspecified blepharoconjunctivitis, unspecified eye |
| H10.52 | Angular blepharoconjunctivitis |
| H10.521 | Angular blepharoconjunctivitis, right eye |
| H10.522 | Angular blepharoconjunctivitis, left eye |
| H10.523 | Angular blepharoconjunctivitis, bilateral |
| H10.529 | Angular blepharoconjunctivitis, unspecified eye |
| Dacryocystitis | |
| H04.30 | Unspecified dacryocystitis |
| H04.301 | Unspecified dacryocystitis of right lacrimal passage |
| H04.302 | Unspecified dacryocystitis of left lacrimal passage |
| H04.303 | Unspecified dacryocystitis of bilateral lacrimal passages |
| H04.309 | Unspecified dacryocystitis of unspecified lacrimal passage |
| H04.31 | Phlegmonous dacryocystitis |
| H04.311 | Phlegmonous dacryocystitis of right lacrimal passage |
| H04.312 | Phlegmonous dacryocystitis of left lacrimal passage |
| H04.313 | Phlegmonous dacryocystitis of bilateral lacrimal passages |
| H04.319 | Phlegmonous dacryocystitis of unspecified lacrimal passage |
| H04.32 | Acute dacryocystitis |
| H04.321 | Acute dacryocystitis of right lacrimal passage |
| H04.322 | Acute dacryocystitis of left lacrimal passage |
| H04.323 | Acute dacryocystitis of bilateral lacrimal passages |
| H04.329 | Acute dacryocystitis of unspecified lacrimal passage |
| H04.41 | Chronic dacryocystitis |
| H04.411 | Chronic dacryocystitis of right lacrimal passage |
| H04.412 | Chronic dacryocystitis of left lacrimal passage |
| H04.413 | Chronic dacryocystitis of bilateral lacrimal passages |
| H04.419 | Chronic dacryocystitis of unspecified lacrimal passage |
| P39.1 | Neonatal conjunctivitis and dacryocystitis |
| Keratoconjunctivitis | |
| H16.20 | Unspecified keratoconjunctivitis |
| H16.201 | Unspecified keratoconjunctivitis, right eye |
| H16.202 | Unspecified keratoconjunctivitis, left eye |
| H16.203 | Unspecified keratoconjunctivitis, bilateral |
| H16.209 | Unspecified keratoconjunctivitis, unspecified eye |
| Meibomianitis | |
| H00.02 | Hordeolum internum |
| H00.021 | Hordeolum internum right upper eyelid |
| H00.022 | Hordeolum internum right lower eyelid |
| H00.023 | Hordeolum internum right eye, unspecified eyelid |
| H00.024 | Hordeolum internum left upper eyelid |
| H00.025 | Hordeolum internum left lower eyelid |
| H00.026 | Hordeolum internum left eye, unspecified eyelid |
| H00.029 | Hordeolum internum unspecified eye, unspecified eyelid |
| Respiratory cystic fibrosis p. aeruginosa colonization | |
| B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
| E84.0 | Cystic fibrosis with pulmonary manifestations |
| Synergy for p. aeruginosa infection in cystic fibrosis | |
| B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
| E84.0 | Cystic fibrosis with pulmonary manifestations |
| 0-9 | A-Z |
|---|---|
| B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
| B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
| E84.0 | Cystic fibrosis with pulmonary manifestations |
| E84.0 | Cystic fibrosis with pulmonary manifestations |
| H00.02 | Hordeolum internum |
| H00.021 | Hordeolum internum right upper eyelid |
| H00.022 | Hordeolum internum right lower eyelid |
| H00.023 | Hordeolum internum right eye, unspecified eyelid |
| H00.024 | Hordeolum internum left upper eyelid |
| H00.025 | Hordeolum internum left lower eyelid |
| H00.026 | Hordeolum internum left eye, unspecified eyelid |
| H00.029 | Hordeolum internum unspecified eye, unspecified eyelid |
| H01.0 | Blepharitis |
| H01.00 | Unspecified blepharitis |
| H01.001 | Unspecified blepharitis right upper eyelid |
| H01.002 | Unspecified blepharitis right lower eyelid |
| H01.003 | Unspecified blepharitis right eye, unspecified eyelid |
| H01.004 | Unspecified blepharitis left upper eyelid |
| H01.005 | Unspecified blepharitis left lower eyelid |
| H01.006 | Unspecified blepharitis left eye, unspecified eyelid |
| H01.009 | Unspecified blepharitis unspecified eye, unspecified eyelid |
| H01.00A | Unspecified blepharitis right eye, upper and lower eyelids |
| H01.00B | Unspecified blepharitis left eye, upper and lower eyelids |
| H01.01 | Ulcerative blepharitis |
| H01.011 | Ulcerative blepharitis right upper eyelid |
| H01.012 | Ulcerative blepharitis right lower eyelid |
| H01.013 | Ulcerative blepharitis right eye, unspecified eyelid |
| H01.014 | Ulcerative blepharitis left upper eyelid |
| H01.015 | Ulcerative blepharitis left lower eyelid |
| H01.016 | Ulcerative blepharitis left eye, unspecified eyelid |
| H01.019 | Ulcerative blepharitis unspecified eye, unspecified eyelid |
| H01.01A | Ulcerative blepharitis right eye, upper and lower eyelids |
| H01.01B | Ulcerative blepharitis left eye, upper and lower eyelids |
| H01.02 | Squamous blepharitis |
| H01.021 | Squamous blepharitis right upper eyelid |
| H01.022 | Squamous blepharitis right lower eyelid |
| H01.023 | Squamous blepharitis right eye, unspecified eyelid |
| H01.024 | Squamous blepharitis left upper eyelid |
| H01.025 | Squamous blepharitis left lower eyelid |
| H01.026 | Squamous blepharitis left eye, unspecified eyelid |
| H01.029 | Squamous blepharitis unspecified eye, unspecified eyelid |
| H01.02A | Squamous blepharitis right eye, upper and lower eyelids |
| H01.02B | Squamous blepharitis left eye, upper and lower eyelids |
| H04.30 | Unspecified dacryocystitis |
| H04.301 | Unspecified dacryocystitis of right lacrimal passage |
| H04.302 | Unspecified dacryocystitis of left lacrimal passage |
| H04.303 | Unspecified dacryocystitis of bilateral lacrimal passages |
| H04.309 | Unspecified dacryocystitis of unspecified lacrimal passage |
| H04.31 | Phlegmonous dacryocystitis |
| H04.311 | Phlegmonous dacryocystitis of right lacrimal passage |
| H04.312 | Phlegmonous dacryocystitis of left lacrimal passage |
| H04.313 | Phlegmonous dacryocystitis of bilateral lacrimal passages |
| H04.319 | Phlegmonous dacryocystitis of unspecified lacrimal passage |
| H04.32 | Acute dacryocystitis |
| H04.321 | Acute dacryocystitis of right lacrimal passage |
| H04.322 | Acute dacryocystitis of left lacrimal passage |
| H04.323 | Acute dacryocystitis of bilateral lacrimal passages |
| H04.329 | Acute dacryocystitis of unspecified lacrimal passage |
| H04.41 | Chronic dacryocystitis |
| H04.411 | Chronic dacryocystitis of right lacrimal passage |
| H04.412 | Chronic dacryocystitis of left lacrimal passage |
| H04.413 | Chronic dacryocystitis of bilateral lacrimal passages |
| H04.419 | Chronic dacryocystitis of unspecified lacrimal passage |
| H10.02 | Other mucopurulent conjunctivitis |
| H10.021 | Other mucopurulent conjunctivitis, right eye |
| H10.022 | Other mucopurulent conjunctivitis, left eye |
| H10.023 | Other mucopurulent conjunctivitis, bilateral |
| H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
| H10.3 | Unspecified acute conjunctivitis |
| H10.30 | Unspecified acute conjunctivitis, unspecified eye |
| H10.31 | Unspecified acute conjunctivitis, right eye |
| H10.32 | Unspecified acute conjunctivitis, left eye |
| H10.33 | Unspecified acute conjunctivitis, bilateral |
| H10.5 | Blepharoconjunctivitis |
| H10.50 | Unspecified blepharoconjunctivitis |
| H10.501 | Unspecified blepharoconjunctivitis, right eye |
| H10.502 | Unspecified blepharoconjunctivitis, left eye |
| H10.503 | Unspecified blepharoconjunctivitis, bilateral |
| H10.509 | Unspecified blepharoconjunctivitis, unspecified eye |
| H10.52 | Angular blepharoconjunctivitis |
| H10.521 | Angular blepharoconjunctivitis, right eye |
| H10.522 | Angular blepharoconjunctivitis, left eye |
| H10.523 | Angular blepharoconjunctivitis, bilateral |
| H10.529 | Angular blepharoconjunctivitis, unspecified eye |
| H16.20 | Unspecified keratoconjunctivitis |
| H16.201 | Unspecified keratoconjunctivitis, right eye |
| H16.202 | Unspecified keratoconjunctivitis, left eye |
| H16.203 | Unspecified keratoconjunctivitis, bilateral |
| H16.209 | Unspecified keratoconjunctivitis, unspecified eye |
| P39.1 | Neonatal conjunctivitis and dacryocystitis |
Formulary Reference Tool